About Us
Who We Are
LimeRiver Biotechnologies INC is a fully integrated biosciences company dedicated to the discovery and development of therapeutic antibodies derived from natural human immunity.
Our True Human™ antibody candidates are actually derived from donors with natural human immunity. No other marketed antibody product — including "humanized" and so-called "fully human" — are actually derived from natural human immunity.
Founded on the principle that nature holds the key to the most effective treatments, LimeRiver combines cutting-edge biotechnology with the power of natural immunity to develop breakthrough therapies for some of the world's most challenging diseases.
Our state-of-the-art facilities and world-class team of scientists are dedicated to advancing our pipeline of True Human antibodies through clinical development, with programs spanning oncology, neurology, rheumatology, and infectious diseases.
Leadership
Meet Our Leadership Team
Our leadership team brings together decades of experience in biotechnology, research, and clinical development.
Dr. Micheal Hartwell
Founder, Chairman of the Board, Scientific Advisor
Dr. Elena Vasquez
Chief Scientific Officer, Interim Chief Executive Officer
Dr. James Nakamura
Senior Vice President of Clinical Operations and Analytical Quality
Sarah Mitchell
Vice President of Quality
Dr. Robert Andersson
Vice President of Manufacturing
Stephen Tomie
Hiring Manager
Guiding Our Vision
Board of Directors
The Board of Directors is committed to supporting the company's strategic direction and achieving its mission. Their diverse backgrounds in science and business provide invaluable insights and governance.
Dr. Micheal Hartwell
Founder, Chairman of the Board, Scientific Advisor
Dr. William Hartley
B.Sc. DMD
Dr. Catherine Brooks
M.A., Ph.D.
Dr. Marcus Lindqvist
M.D.
Jonathan Reed
B.Sc.